{
    "code": "56027531",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56027531",
    "time": "2022-12-16 06:48:41",
    "許可證字號": "衛部醫器輸字第027531號",
    "註銷狀態": "已註銷",
    "註銷日期": "111\/10\/28",
    "註銷理由": "公司歇業",
    "製造許可登錄編號": "QSD7455",
    "有效日期": "114\/07\/21",
    "發證日期": "104\/07\/21",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05602753105",
    "中文品名": "因諾-立帕核酸探針式人類白血球抗原試劑組-DRB1位點",
    "英文品名": "INNO-LiPA HLA-DRB1 Plus",
    "效能": "本產品是一種線型探針測定法，提供於體外使用，其設計用來測定人類白血球抗原(HLA) DRB1等位基因之等位基因組(DRB1* 01到DRB1* 16)分子的分型。",
    "醫器規格": "80635 (20T)、80684 (100T)。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B0001人類白血球抗原分型盤",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "1401804100  台富製藥股份有限公司",
    "申請商地址": "桃園市大園區和平西路一段391號",
    "主製造廠": [
        {
            "製造廠名稱": "MBE0826000  FUJIREBIO EUROPE N.V.",
            "製造廠廠址": "TECHNOLOGIEPARK 6 B-9052 GENT, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560275310001-104-08-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027531&Seq=001&Type=9"
        },
        {
            "title": "560275310002-104-08-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027531&Seq=001&Type=8"
        }
    ]
}